<SEC-DOCUMENT>0000950157-12-000240.txt : 20120614
<SEC-HEADER>0000950157-12-000240.hdr.sgml : 20120614
<ACCEPTANCE-DATETIME>20120614083726
ACCESSION NUMBER:		0000950157-12-000240
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20120614
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20120614
DATE AS OF CHANGE:		20120614

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			JOHNSON & JOHNSON
		CENTRAL INDEX KEY:			0000200406
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				221024240
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1212

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-03215
		FILM NUMBER:		12906411

	BUSINESS ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933
		BUSINESS PHONE:		732-524-2455

	MAIL ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<html>
<head>
    <title>form8-k.htm</title>
    <!--Licensed to: Cravath, Swaine & Moore LLP-->
    <!--Document Created using EDGARizer 2020 5.4.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="TEXT-INDENT: 0pt; DISPLAY: inline; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 2%; FONT-SIZE: 10pt; MARGIN-RIGHT: 2%">
<div>&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div>&#160;</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">UNITED STATES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">WASHINGTON, DC 20549</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 18pt; FONT-WEIGHT: bold">FORM 8-K</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">CURRENT REPORT</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to Section 13 or 15(d) of the</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Securities Exchange Act of 1934</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Date of report (Date of earliest event reported):&#160;&#160;June 14, 2012</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block"><img src="jjlogo.jpg" alt=""></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Exact name of registrant as specified in its charter)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="32%" style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: #000000 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">New Jersey</font></div>
</td>
<td valign="top" width="30%" style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: #000000 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">I-3215</font></div>
</td>
<td valign="top" width="25%" style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: #000000 0.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22-1024240</font></div>
</td>
</tr><tr>
<td valign="top" width="32%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(State or Other Jurisdiction of Incorporation)</font></div>
</td>
<td valign="top" width="30%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Commission File Number)</font></div>
</td>
<td valign="top" width="25%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(IRS Employer Identification No.)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">One Johnson &amp; Johnson Plaza, New Brunswick, New Jersey&#160;&#160;08933</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Address of Principal Executive Offices) (Zip Code)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Registrant&#8217;s telephone number, including area code:&#160;&#160;732-524-0400</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">o</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">o</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">o</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">o</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: blue" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 2.01. Completion of Acquisition or Disposition of Assets.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On <font style="DISPLAY: inline">June 14, 2012</font>, pursuant to the Agreement and Plan of Merger dated as of April 26, 2011 (the &#8220;Merger Agreement&#8221;) by and among Johnson &amp; Johnson, a New Jersey corporation, Samson Acquisition Corp., a Delaware corporation (&#8220;Merger Sub&#8221;), and Synthes, Inc., a Delaware corporation (&#8220;Synthes&#8221;), Merger Sub merged with and into Synthes (the &#8220;Merger&#8221;), with Synthes surviving the Merger.&#160;&#160;As previously disclosed, Johnson &amp; Johnson assigned the Merger Agreement to Janssen Pharmaceutical, <font style="DISPLAY: inline">a company organized under the laws of Ireland </font>and a wholly owned subsidiary of Johnson &amp; Johnson, as permitted by the terms of the Merger Agreement.&#160;&#160;&#160;As a result of the Merger, Synthes became a wholly owned subsidiary of Janssen Pharmaceutical.&#160;&#160;Synthes will now be integrated with Johnson &amp; Johnson&#8217;s DePuy franchise, a family of companies providing healthcare solutions in orthopaedics, spinal care, sports medicine and neurosciences, to establish the DePuy Synthes Companies of Johnson &amp; Johnson.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At the effective time of the Merger, each outstanding share of Synthes common stock was automatically converted into the right to receive CHF 55.65 in cash and 1.7170 shares of Johnson &amp; Johnson common stock (subject to the payment of cash in lieu of fractional shares).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The stock portion of the merger consideration consisted of shares of Johnson &amp; Johnson common stock purchased by Janssen Pharmaceutical from Goldman, Sachs &amp; Co. and JPMorgan Chase Bank, N.A., pursuant to two accelerated share repurchase agreements dated June 12, 2012, which were previously reported on a Current Report on Form 8-K filed on June 12, 2012.&#160;&#160;Janssen Pharmaceutical used cash on hand to satisfy the cash portion of the merger consideration.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The foregoing description of the Merger and the Merger Agreement is qualified in its entirety by reference to the Merger Agreement, which was filed as Exhibit 2.1 to the Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission on May 2, 2011, and is incorporated herein by reference.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A copy of the press release announcing the completion of the Merger is attached as Exhibit 99.1 to this report.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 9.01. Financial Statements and Exhibits.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a)&#160; <font style="FONT-STYLE: italic; DISPLAY: inline">Financial statements of business acquired.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The financial statements required by Item 9.01(a) of Form 8-K will be filed by amendment within 71 calendar days after the date on which this Current Report on Form 8-K must be filed.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(b) &#160;<font style="FONT-STYLE: italic; DISPLAY: inline">Pro forma financial information.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The pro forma financial statements required by Item 9.01(b) of Form 8-K will be filed by amendment within 71 calendar days after the date on which this Current Report on Form 8-K must be filed.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(c) &#160;<font style="FONT-STYLE: italic; DISPLAY: inline">Shell company transactions.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Not applicable.</font><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(d)&#160; <font style="FONT-STYLE: italic; DISPLAY: inline">Exhibits</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div align="right">
<div align="left">
<table cellpadding="0" cellspacing="0" width="94%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-WEIGHT: bold">Exhibit No.</font></font></td>
<td align="left" valign="top" width="91%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-WEIGHT: bold">Description</font></font></td>
</tr><tr>
<td align="left" valign="top" width="9%">&#160;</td>
<td align="left" valign="top" width="91%">&#160;</td>
</tr><tr>
<td align="left" valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">99.1</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Press release, dated June 14, 2012.</font></font></div>
</div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>
</div>
</div>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">2</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: blue" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><br>
&#160;</div>
</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNATURES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div>&#160;</div>

<div>
<div>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="38%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Johnson &amp; Johnson</font></font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Registrant)</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date:&#160;&#160;June 14, 2012</font></div>
</td>
<td valign="top" width="3%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By: </font></div>
</td>
<td align="left" nowrap valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ DOUGLAS K. CHIA</font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: #ffffff solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" nowrap valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Douglas K. Chia</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Secretary</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">3</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: blue" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EXHIBIT INDEX</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div align="right">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-WEIGHT: bold">Exhibit No.</font></font></td>
<td align="left" valign="top" width="91%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-WEIGHT: bold">Description</font></font></td>
</tr><tr>
<td align="left" valign="top" width="9%">&#160;</td>
<td align="left" valign="top" width="91%">&#160;</td>
</tr><tr>
<td align="left" valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">99.1</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Press release, dated June 14, 2012.</font></font></div>
</div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div style="TEXT-ALIGN: center">4</div>

<div style="TEXT-ALIGN: left">
<hr style="COLOR: blue" noshade size="2">
 &#160;</div>
</div>
</div>
</div>
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html>
<head>
    <title>ex99-1.htm</title>
    <!--Licensed to: Cravath, Swaine & Moore LLP-->
    <!--Document Created using EDGARizer 2020 5.4.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="TEXT-INDENT: 0pt; DISPLAY: inline; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 2%; FONT-SIZE: 10pt; MARGIN-RIGHT: 2%">
<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold">Exhibit 99.1</font></div>

<div>&#160;</div>

<div style="TEXT-ALIGN: center"><img src="jjlogo.jpg" alt=""></div>

<div style="TEXT-ALIGN: center">&#160;</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Press Contacts:</font></div>
</td>
<td align="left" valign="top" width="25%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Al Wasilewski</font></div>
</td>
<td align="left" valign="top" width="27%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Lorie Gawreluk</font></div>
</td>
<td align="left" valign="top" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Bill Price</font></div>
</td>
</tr><tr>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="25%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(732) 524-1130</font></div>
</td>
<td align="left" valign="top" width="27%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(732) 524-1413</font></div>
</td>
<td align="left" valign="top" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(732) 524-6623</font></div>
</td>
</tr><tr>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="25%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(732) 447-5918 (M)</font></div>
</td>
<td align="left" valign="top" width="27%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(908)764-0873 (M)</font></div>
</td>
<td align="left" valign="top" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(732) 668-3735 (M)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Investor Contacts:</font></div>
</td>
<td align="left" valign="top" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Louise Mehrotra</font></div>
</td>
<td align="left" valign="top" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Lesley Fishman</font></div>
</td>
<td align="left" valign="top" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Ellen Sipos</font></div>
</td>
<td align="left" valign="top" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stan Panasewicz</font></div>
</td>
</tr><tr>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(732) 524-6491</font></div>
</td>
<td align="left" valign="top" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(732) 524-3922</font></div>
</td>
<td align="left" valign="top" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(732) 524-3709</font></div>
</td>
<td align="left" valign="top" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(732) 524-2524</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">Johnson &amp; Johnson Announces Completion of Synthes Acquisition</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">Combination Creates the World&#8217;s Leading Orthopaedics Business</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.5; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">New Brunswick, NJ (June 14, 2012) &#8211; Johnson &amp; Johnson today announced the completion of the acquisition of Synthes, Inc. for a total purchase price of $19.7 billion in cash and stock. Synthes will now be integrated with the DePuy franchise to establish the DePuy Synthes Companies of Johnson &amp; Johnson.</font></div>

<div style="LINE-HEIGHT: 1.5; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;The completion of the Synthes acquisition creates the world&#8217;s most innovative and comprehensive orthopaedics business and reflects our long-standing strategy of leadership within attractive health care markets,&#8221; said Alex Gorsky, Chief Executive Officer, Johnson &amp; Johnson. &#8220;The combination of these two respected leaders&#160;-- Synthes and DePuy --&#160;&#160;will enable us to better serve clinicians and patients worldwide, bring new innovations to the orthopaedics and neurological marketplace, and strengthen our ability to compete in developing markets.&#8221;</font></div>

<div style="LINE-HEIGHT: 1.5; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;This is a very exciting day for the people of Synthes and DePuy as we become one comprehensive enterprise dedicated to advancing patient care through innovative, total solutions that are developed from a deep understanding of our customers&#8217; needs,&#8221; said Michel Orsinger, Worldwide Chairman, Global Orthopaedics Group, and former CEO of Synthes. &#8220;We are building on the legacy and strengths of two great companies to create one organization that will be agile and responsive in today&#8217;s evolving health care environment.&#8221;</font></div>

<div style="LINE-HEIGHT: 1.5; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.5; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: blue" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.5; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.5; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Under the terms of the agreement, each share of Synthes common stock will be exchanged for CHF55.65 in cash and 1.7170 shares of Johnson &amp; Johnson common stock.&#160;&#160;Cash will be provided for fractional shares. Further information regarding closing instructions for Synthes shareholders can be found on <font style="DISPLAY: inline; COLOR: #0000ff; TEXT-DECORATION: underline">www.investor.jnj.com</font> or <font style="DISPLAY: inline; COLOR: #0000ff; TEXT-DECORATION: underline">www.Synthes.com</font>.</font></div>

<div style="LINE-HEIGHT: 1.5; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.5; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">About Johnson &amp; Johnson</font></font></div>

<div style="LINE-HEIGHT: 1.5; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Caring for the world, one person at a time, inspires and unites the people of Johnson &amp; Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 129,000 employees at more than 250 Johnson &amp; Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.</font></div>

<div style="LINE-HEIGHT: 1.5; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">NOTE TO INVESTORS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(This communication contains &#8220;forward-looking statements&#8221; as defined in the Private Securities Litigation Reform Act of 1995. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson &amp; Johnson.&#160;&#160;Risks and uncertainties include, but are not limited to, general industry conditions and competition; economic factors, such as interest rate and currency exchange rate fluctuations; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; challenges to patents; significant adverse litigation; impact of business combinations; financial distress and bankruptcies experienced by significant customers and suppliers; changes to governmental laws and regulations and domestic and foreign health care reforms; trends toward health care cost containment; increased scrutiny of the health care industry by government agencies; changes in behavior and spending patterns of purchasers of health care products and services; financial instability of international economies and sovereign risk; disruptions due to natural disasters; manufacturing difficulties or delays; product efficacy or safety concerns resulting in product recalls or regulatory action. In addition, there are risks and uncertainties related to Johnson &amp; Johnson&#8217;s ability to successfully integrate the businesses of DePuy and Synthes, as well as the ability to ensure continued performance or market growth of Synthes&#8217; products. A further list and description of these risks, uncertainties and other factors and the general risks associated with the respective businesses of Johnson &amp; Johnson and Synthes can be found in Exhibit 99 of Johnson &amp; Johnson&#8217;s Annual Report on Form 10-K for the fiscal year ended January 1, 2012, and Synthes&#8217; 2011 Audited Financial Statements. Copies of these filings, as well as subsequent filings, are available online at www.sec.gov, www.jnj.com, www.synthes.com or on request from Johnson &amp; Johnson.&#160;&#160;Johnson &amp; Johnson does not undertake to update any forward-looking statements as a result of new information or future events or developments.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">2</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>jjlogo.jpg
<TEXT>
begin 644 jjlogo.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``,"`@,"`@,#`P,$`P,$!0@%!00$
M!0H'!P8(#`H,#`L*"PL-#A(0#0X1#@L+$!80$1,4%145#`\7&!84&!(4%13_
MVP!#`0,$!`4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P``1"``^`4P#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#]3;R\@T^T
MFNKF9+>VA0R22R,%5%`R22>@`KYLUC]H?Q#\2]-\3:G\/YK3PYX%\/Q2M>>,
M]4@\XW#HI)2TA)`;L-S<<CCD`\/^WO\`%74=0U7P]\(/#TYCNM;>)]1:-N2D
MDFR&$X[$Y8CN`OKS-^V@EE\$?V6/#_P_T/\`T>"]FBL3LX,D<:F25CW)9PI/
M^]7DU\2_WG*[*"U\WT7^9^J9)PY%+`RKQ4JN+G:":NHTT_>FULV]>5/2R;=S
MWG]F/Q)XA\8_`[POKOBB\-_K&HPO<O,8UC)1I&\O*J`/N;>E>I5Q7P3LDT[X
M/>";:,`)'HUH!C_KBIKM:]&DFJ<4][(_/<SG">.KRIQ2BYRLEHDKNRL%%%<5
M\:_$DOA#X1>,=9@8I/9Z5<2Q,.JOY9"G\R*N4E&+D^ARX>C+$UH4(;R:2]6[
M'S=XW_:K\=>+O$?CL_#)=(M_#/@:U:YOK_4XFF-^RL04CP1M!VO@]2%SW&?I
MKX3^.T^)WPV\.>*D@^R_VK9QW+0`Y$;D?,H/<!@17YV_`W7H?"G[)?QHNF)>
M_P!4N+72;=!\S222I@*.>?OL?PK]"/@IX0D\`_"3PCX?G!%Q8:;#%,#U$FT%
MQ_WT37DX&K4K/FD]U>W;5V_`_4N,\KP.4TGA</2494ZG(I=9)4XN;EW]Z2MV
MV1VU%%%>P?DH4444`%%%%`!1110`4444`%%%%`!1110!C>,/&&C^`?#E]KVO
M7\6FZ59IYDUQ*<`>@'J2>`!R37RI\4_VA_B-K'PDU3XA>'Y;?P%X4W)#HJWE
MJMQJ6KN[!4;:WR1(>2.&)`/X\K\=_$MU^TG^U5X?^$]M<,OA/1KL'4$C;`GD
M1=\Y.#SM7]V,]"6/>KO[=GB&*3XA_"?X?VH2#38;J"\EMTX4`S)#$N/0*'_.
MO%Q&)E*-1Q=E'1>;_P"`?LF2<.T<)B<%2Q,%.M6BZLDU=0I13:5GHY3L]7?E
M6ROJ?9WA?[=_PC.D?VG)YNI?9(?M4FT#=+L&\X'`RV>E:=%%>RM#\>G+FDY6
MM<*HZYK5GX;T:^U749UMK"R@>XGF;HB*"6/Y"KU?/'[>?B.?P_\`LXZS'`YC
M;4KJWL&(Z[&?<P_$(1^-95JGLJ<JG97/4RC`/-,PH8%.WM)1C][L>27/[8_Q
M'O\`1;GXGV&G:3:_#2UUR+2%TNXC9KRY1OO2>8#A6`(XQC)Q@XY^W;:X2[MX
MIXSF.1`ZGV(R*_./3;0Z_P#LG_"7P#9*)-5\6>+'D"#DB*.9_,<\]`"OX9K]
M'8(5MX8XD&$10H'L!BN'!3J3NYN^B?S>K_0^TXRP>"P;A#"TE3:G5BK=80:C
M%ONW)3UZ_(DHHHKU#\T"BBB@`HHHH`****`"BBB@`HHHH`_.[QX[:A_P4ATM
M+L[ECU:Q5%;D`+;*5_7G\?SZ3_@IY-(?^%?P9/E$7KX[;L1#^1JA^VIH%Y\*
M?VB_!OQ5MXI&TZ>:V>>1!PL]NP!0_P"]%C'K@UT__!1NTM_$7PS\!^*+&19[
M-;Q@DR<AHYX=RG/OL'YU\M5BU1Q5-[WO\G8_IK*Z].KF_#>-A_#=)T_2<5*+
M7K=H^DO@GK]H?@/X,U6ZN8K>S30[:26XF<*B*L2AF+'@`8/->3-^V;%X\^*>
MF>!OA?HR>(YYYB+C6+UVCM8HEYDD0#YG`7OQDD`9R,^5_L]^`_%O[1GPQ\-Z
M9XDG?2OA9X=A-NFGV<A677)D8G]XP.1&O`QW(_&N3_X)XW-C;_'SQ+#.L<%U
M+IDZ6L.<;=LZED4'T7'X"NOZW4DZ,(Z*77KHNA\M_JQEV&AF^*Q+]K6P]VH)
M^['FDU'F:U;2]YI:+9MNZ7LVC_MSWT^KWFK:CX%N+;X;0:JVD2>(89_,DM9`
M<!IH^P.0?;/4GKZ3^UCXY\/Z5\`?%UO=:U8P7.IZ6\5E"TZ[[EG7Y`BYRV<]
M1Q7GW[3G[+?P_L_!'CCQQ!)J'A^[%I+>W%O8W92SN9^JF2(Y!+,1TQR?7KP.
ME?L]>#+#]C>]\>76BO=^+[GPT]U]NOYGF:%RO!C5CA>,8P*N4\3'GI3L]&[_
M`/#+^NYRT,)P[B7@\SPO/3M5A!P2O>7NM7<IOSNUNK>ZF<;^PC\)I_B3J\VH
MZK<JWA/PWJ*7XT[/_'SJ!CQ&SC^ZB\\]2?K7K/C3_@H19:-\78O#FB:+!JOA
MJ"]2QN]5:<AW8N$=X0."JD]_O8XQD9\(_9N\=ZI9?"WQ!X!\*3;/&?C/68;"
MU=#S:6WD_O[D^@5,X/J?SS?VJ?`FD_#'XX>%?#.BP+#8Z?I>FQ`@8:1O-;=(
MW/+,>2??\_+I5IT,)"5%VU5WZO;[C])S#*<)G/%.+I9Q'F7+/V45=)*,4W-V
MU;<G9=[/LC]-_%GBK3?!/AG4M?U>X6UTS3X&N)Y3V4#MZD]`.Y(%?,?P#_;C
MG^,OQ>3PI<^&X=+TZ^29K"X2<O,"B[P)!TY4'[O0^M;/Q*NG_:2^,MI\--.=
MG\#^&)8]0\574;?)<S@YALL@\\C+#_#GY*\"^,-&^$_[7OB#7K\)9Z1HVH:N
MPAB`4`!952-!TY)50!Z_GZF*Q4X5:;@[0O9^??Y(_-^&^&,%C,LQL,33<\5[
M+VD$F_<3^#1;REO9[1MW/L3]J;]KJT^`-Q8:+I=A!K?B:[3SWMYY2D5M#G`9
M]O.6/0<=,^F?3O@7\44^,OPNT3Q:+/[!)?(PFM@VX1R(Y1@#W&5R/8U\/?M!
M^!-0M/V=[;Q_XJB!\:>,O$,.H718?-:6QAE\BV7T"IMX'<^W/HOPD^+L_P`+
MOV,O"UMHJ"]\9Z]=7.FZ%8KR\EP\[CS,?W4SN)^GK13Q518F2J/W>6Z7S_,K
M'<+X"7#N&J8"/-B'6=.4[Z.T6Y>2C%K?LKO<]D\-_M0Z5X@_:3UOX8J8!;6M
ML$M+T-S->)EIXNN.%(Q[HWM75?%W]H/PA\&84BUB[DO-9F4M;Z-IR>==S#'7
M8/NK_M-@5^<WQ]^'C?LV_$/PQ_8OB>2^\60V46IZA,'W26U_N+%L^C]0#SC.
M>O/TQXC\#Z3X,_8]\3^/]*N9]<\7^)=(AN;_`,2WQWW4@G=!(JD_<0!V&U>/
MK44L96?M(25I1N_EV]3;,>$LHH/+L90G*5'$<L$K.+E._*Y-N_+%[[-OHK:K
M0\%_MO:[XSTSQCXJC\%P6G@GPQ9F>YE:Z+W,LK<0Q*0`H))RQYPO/IGJOA!^
MUO>>)M?TG2/'WA8>"GUVT-]HNHFY#VEY$!N*[S]UL<_X9&>/_P"">=CHGB3X
M#^*-$O+:"]6;5)HM0M90&$D4D2!0P]"N1^!KAOVJ?V:/!GPOT[P8-$GU:4ZG
MX@@LH='N[]YK=(7/[U8D/*Y^49![_F1JXGV$,0I7TNU\_P"OF:8C+.'IYUBL
MAG0=*2ERPDN:324;WUDM6_>=TTXNVEKGH'QK_;\T_P`'WK6G@71U\50P2^1<
M:S,76P$HZQ1NH_>-CN#CTS7M_P`-_CCI?C+X'V7Q(U54T2P-I)<7BN^Y8#&S
M*X![C*G'<Y%>"_M^^%]'\%_L]^&-&T/3H-*TNVUR%(;6U0(BCR)NW<GN3R>^
M:\^^!TLGQM\!?#/X/V3M_85D9];\6/&>#`MRY@MB?^FC8)'IC\7]9K4\5*E-
MWT5EYO\`$YY9!E&/X;P^986DZ:C5DIS;O)PC%MM_93>BBDMVE=GI_P`$_P!N
MQ_BU\8[?PK+X;CTW2-1,J6%R)RTX95++Y@Z?,%/3H2.M?7%?F5\*[6"Q_;[-
MK:PI;6T/B'4$BAC`544+*`H`[8_SZ_;_`,:OC]I7PL^'?B7Q#IP@\0WVB3Q6
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M+==YN5!_0G_/7)_;<U-K3]K/2[B1L1V4&FR+[`2EC_,_YZZ/AS6='^#O[>!O
M;75;&^\.:[=2A+NSN4EB5+H<!F4D#;-Q]/KRW_@I%H;:=\7/#VKKE5OM)V;^
M>&BE;^CC_/7P*EXX*<>L9Z_>?N.#<:_%^%K./N8C"VC_`.`ZKU5G?U/T"\5^
M,=%\#>'[G7->U*WTO2K==TES</A1Z`>I/8#)/:OG'PW^VK+\0?$7B&X\+^%W
ME\$^&=/EU'4]5O7*SRHJL42*,<!G(XW'H"2*\]\9>`/%WQ?^#&O?%'XC2/%;
M6&B/-X;\*P2$00#RQB[FY^>0CY@#TX^E:'_!-8:9J'@GQ]ILRQ3SRWD/VB"0
M!O,@:$J`1W4GS!^/OSZ\L35J8B%./NIIOS?]?>?EM'AS+,OR/&9AB/W]:E.,
M&D_<BY-7LU\32TO\*EM>USN_A'^V)J'BO7/#MKXT\'MX5TSQ3D:#J\5QYUO<
M."0(W/\`"QZ#W(XY!K%_X*(^,=#D^$5KX?35[-];?5K><6"3*TPC57W,5'(`
MW#KZUPG[7G[,O@OX4?#U-=\-WFJZ=<S:K!#9Z.;YGM4>1CN,4;9*D#)!!XJ7
M]KG]GKP1\(/V?H+_`,/Z-Y&M7&JVD<^I74SSW+@JY92[$X!(Z#%<]:>(]C5I
M5+.RW]?1>1[F4X/()9OEF9X%S@JE7E4%'3FBUJW*;:5I1O:]VG:QI_L0?#^'
M3/!,7Q7\7:C$--T>TN;71XG/R6-N'9KB9O\`;9MP]<`^M=%\)/V\%^*7QML_
M"<?AU+/P_J4DD-C>F8FXW*K,K.O3#!3P.1D=:\O^"-U/\9/AE\/?@QI4SKI?
MF3ZMXLGB.-EFMPQCM\CO*V,CTQ^/*>$K.UT?_@H(+6VBCL[*U\1W,<<48")'
M&L+X`Z8`'^?7&%:=*%!4G:+:3\V]_N_K8];%Y3A<TQN<5,TAS5H0J3II:*G&
M,FHNRZR=Y:]-7\1]\?&SXOZ3\$/A]?\`B?5AYPBQ%;6BN%>YF;[L8)Z>I/8`
MFO+?V4/VK;O]H74?$&FZGHMOI%]IT<=S$;24NCQ,2N#GG<"!['/Y\M/&/VG_
M`!GXF\:74?VCX<^#K.\L]!@E7,6H7WE,);H@\,J]%_#WS\M?LH_%27X61>-[
MK38S=^)]4TVWTW1;1>6FNY9MJ<9Y"YW'Z>_/55QDXXB#O:#O\[=?\CYK+.$\
M'B<@QD'3<L;3]F[WTASOX>VD=9M[7M]D^I?VA_V[X?A-X]D\,^'=%M_$$FG$
M#5+B><HJ/P3%'C^(#J3P"<8XKZDT3Q!:ZUX:L-;0^19W=I'>`R$#8C('Y/3@
M'FOS+_;%^%</PBTGX=Z,S+<ZO)IMW=:KJ!Y>[NWE5I'8]3\Q('L/S^F?B)XP
MU+Q/\._AO\'/"<^SQ)XJT:T.HW,9S_9VFB%/-E;'0L,J/7GU&71Q555JL:O2
MUEZ]#/..&<LGE665LM5O:.ISS;>L8/6;6R5DVDNC2U9WO[.W[36G?'?7O&6F
M0I%;RZ3>L;$*3FYL<[4EY[[@<X_O+1\:OVNO!OP>FN].7S_$GB"V3?-INEX;
M[,.QFD^['SC@\^U?`'BBSB^!O[0NJZ+X,\77-GIT5PNF/J]H=TL$,NU9D/9F
M3)Y]1ZU]$_MF?#K1O@G^SUH?A_PK:F"UU'5XSJ5^YWW%ZXC=PTTAY<EAGGCC
M@5C#&UG0J7MS0O=_E8]7$\&Y/3SK`Q@Y.ABU%PAK%I67,Y-[=U%:MO=):]/9
M?MK^*O\`A5-UX^O?!5G%IM[J4>D:':I=,7N)CNWO(Q&`@VX&!R<]AFO2_A?^
MU!:ZY-KVC_$+3$^'?BC0X1=7EIJ%PODO`>DL4A^\.0,#/48SFLS]GSP-X4^+
M7[(GA#P]K%C#J>D2692:(-AHYUD?<P8'*N&).??N#SXMXL_9V\&^%OVKOACX
M30ZAXETZ_M;BXOK/6[QKK9'&KF(9.#LW*?E/''OST<^)A&%12YD[?>_^'/$^
MJ</8VOC,OG0E1J4G5:<;M\M-72UE;51DG=:R::?0UOB1_P`%&_["\11+X8\)
MMJ/AW.Y=2U)G@-Z@.&:!<?=]"<Y]!7TO\2/C=H7PS^$Y\=ZCO:SEMHI;2U!`
MDN))5!CB'N<\GL`3VKXU_P""EUG!8^*?`MK:PI;V\6E7"1PPJ%5%$B@`*.`.
MV*]`\((G[1GB&UOIE%WX"^'6@);P1N,Q7NK-:C>Y'.X1+QWYQZ\YPQ%95JM%
MRN]+?=K]QWXWA_)ZN4Y;FU*@Z=)\[J>\VY*,E&,;O3FF]-$K7;M9'<_LJ?M;
MW?[07B+7=%U/0K?1[NRMUO('M9BZO%OV%6W<[@2O(X.>W?Z5K\XO^";#@?%W
MQ*S,`!H9).>/]?'R>?\`/\_T-T'Q#IGBG3(]1T>_M]3L)&94N;6021L58JP#
M#@X((_"NO+ZTZ^'4JCN]3Y/C[*,+DV>5<-@*?+22@[:NS<;[OOJ9'Q)^'6B_
M%7P;J'AK7[?[1I]XF,CAXG'W9$/9E/(/]*_.+QMH'C[4/AEXR\'QZ]!K?P_^
M&5X2NH1H1]JD9PJP@YY\L.Y('"YZD8K[O_:=^)LOPG^"^O:S9L1JTR+8Z>%&
M2;F4[$(^F2W_``&O/?%'PRM/A-^P]XA\/N`URFAR7%],_+37;@/(S'N=YQ^`
MK/&4HUY./51=_P!%]^IZ/".:5\GHTJLDI1J5H*$6KVDFN>:[/E:CI_-?[*)_
M^"?TS2_LXZ>I.1'J%VHYS@>9G^M>&_'3]DOX@?#_`.*L_CKX5Q3W=M/<M>Q1
MZ?(%NK&5B2ZA2?G0DG&,\$@CU^B/V'=`?0?V;/#!D7:]^9[['M)*Q4_BH!_&
MO>J<,+'$86G&IHTD[K=:&.+XFQ.0\39AB<$HRA4G.,HR5XRCS/1H^$M/^&_[
M0G[3,ECHWQ+F;PQX*AF62]0PQV\MT%.=HC0DL3C@MA1UY[_4OQE\#3ZK\!/%
M'A3PW9*TSZ-)96-FA"@X3"("?8`<UZ11753PL:<6FVV]&WN?-X_B3$8VO1J0
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M/.RWBS,LKJ8NO2DG4Q$7&4GNKO=6V?;HCYW_`&X_AEXA^)GP=M;/PQISZI?V
M.I17;6<&/,>,(Z'8#U(W`X],UR'[&O[,FM^"UM/%OCV*2/5K.%[;1-(G</\`
MV;$Y+2.0"0)')/N!GN:^MZ*'A*<J_P!8>]OD*CQ5CZ&22R*G94W)R;M[VNZO
MT3ZZ7:NKV/SX^+?P`^)7BCQMX[\/VW@PZC<>)/$<>JV_B^291;P6:JX2)B3D
M;0W*]?EZ'C/V7I/PATFT^#%K\.;PM>:4FDC2YG/#.-FTN/0Y^8?A7>44Z6%A
M2E*6[?Y?TR<SXGQN94*&'DE"-)IKEOK))1YM6[:15DK):Z:GYL67P+^/O[,O
MCF\G\"VEUK%G-\BW>GHL\-U$"=OFPL<JP]QP2<'U]K^$'P/^)WQ.^)>D_$7X
MTW"PKHO[S2="78-LO9V1"50`\X)+$@9X'/UY17/3R^G3>DGRWO:^A[F8<>8_
M,:3YZ%*-:4>6551_>.-K/6^EUHVEMM8^<?V[/ASXC^)/PAT^S\,:7/K%]::O
M%<R6MM@R&/RY$)`)&<%U_#-:?['/P'N/@E\,S_;-ND/BC6)/M5^H(8PJ.(X=
MPZ[1DG'&6/UKWNBNGZM#V_UA[VL?.OB/&_V(LAC94>?G?=OL_)/7U/SA^)7[
M._QC\/\`[2>L:]X+TBZD:^U*:]T_6[=T\F$39W%RQ^0J&8'(]QGO]F_"+X#:
M+\.OA3_PB&HPPZ\U^&FUJ>Z3S!?W$G,C/NR2,\#/8#O7J-%9T<'3H3E..M^_
MGN=V<<7YAG6%H86JHQ5)15XJTI<OP\SOTU:2LDVV?/S?L2>`+&\FGT"_\2>%
M1,VYX-'UB6*(_P#`3FN%^%O[&NA:)\</'$NN>'6U?P?!!:_V/+K$GGF>9UWS
MN>?F(;()8=37UW15O"46T^5:'-3XKSF%*K2>(DU4CRMMN^C3NGO?2WHV>$?&
M?]E+X>>-/`.H6UKI>F^$+VVC-S;ZQ8VZPFW9`3E]N-R<<@_7K7PA\8KGX@?$
MCX4^&_'OBV]BN]&LYSH&ENBE3=*JL6NCGD[R@&3UV]/7[@_;%\1WE[X?\,_#
M72)V@U7QUJ2::\B'#1V@(,[?D0/H37(?MZ>&].\+?LP:1HVFVZ06VGZE9VUG
M"HZ`(Z@?4BO,QM"-15''3E6MNKW7W?J?I/!><XK`5L!'$OVCK5?<YM7"'PS<
M6]5SO3M[K[GM?P;L+?Q3^SQX0L-1C^T6E]X=MK>>-OXT:`*P_$5\37O[./QK
M_9J^(D^J?#B"[UFQ8F.WO+`++YD!.1'/"QY(^A&1D&OOOX7:$WACX:^%=(=2
MLECI=M;N#U#+$H/Z@UU%=U3"1Q$(<S:E'9K='PV7\4XG(\7BUAX1J4:S?-":
MO&2N[:::ZGQI\./@K\6OCAX]T+Q;\:I5L=%T.47-CH(5$,LP.06C0D*,@$EB
M6.`.!G/I?[;W@#Q!\1O@BVG>&M,FU;48-2M[HVMO@R-&NX,5!ZD;AQ7T!16B
MPD/92IMM\V[>YQSXHQ<LRP^8QIPBJ#3A"*M"-G>UD[ZO=WNSP+]C;X$3_!3X
M9%M8ME@\3ZS(+J_3(9H5`Q'"2,_=&2>>K&OFCXA_LH?$CQA^U)X@FL;&XTO0
MM5U&2[_X2*)P(HK:0?/@YSOVEEVXZGTZ_HI143P-*=*%+I$Z\%QIF>"S#%9G
M'EE5Q"<975TKM6LK]+)).ZL<C:>`+#PK\+W\(>';5+:RM],DLK2'.!DQD`D^
MI)R3ZDFOCG]BC]E+Q)X<^(#^+?'.ARZ0FCJR:=;7>"\EP?E,H`)^55S@]RV1
MTR?O2BM*F%IU)PG+[.QYV`XFQ^78+&8*B],3;GD[\W6]G?[5W>Y\:?M^_!/Q
ME\2]7\(:IX7T2?78;:&>TN(;7!>)F965B"1\I`(SVQSUY],_9M_9]U/X8>"]
M1U/7KP7/Q#UNT$-Q>N_F"RC5-L,"'^ZF`3C@D>P->_T4EA*:KRK]6;UN*\?5
MR:CDGNJE3;U2]YIOFLWVOK96O97V/S@\-_LK^/\`QOJG@WPEK'@U_#=IH%]<
MW&M>)9YE==1\R97+1X.7)"@#J.<G'?[:^._P<LOC9\,;_P`*S3"RF;;-976W
M<+>=/N,1W'4'V)KT6BE2P=.E&4=^;>X\SXLS#,L1A\3I3=!MPY;Z2<N9O5O=
M]-DM$K'YN>`_!O[37[/-]?:)X8T&ZN+&>0L5BCCN[-G.!YB$GY"<#/3W''/T
M=^S9\`?%FC^,M2^)WQ1OUU#QSJ$'V>"W5PZV,)ZC*_+N(P,+PHSR22:^E:*S
MHX&%%KWFTMDWHCT,WXUQ>;4JD7AZ5.=16G.$;3FNS=WH[:VW/C']O7X)^-OB
MCXJ\%77A/0IM9BC@FM)FA90('9U*L^2,+C//L?Q^AOA%\'K3X6_!NQ\%6S+Y
MPM'6[N5'^MN)%/F2>_S'CV`KTBBMX86G"M*MUD>-BN)<=BLJPV3RLJ5!MJV[
M;;=WKTN[>I^8GPY_97^-FB^.-3\-65G=^&=-U&-M.U/74=?(>SW@L4<'+%@.
M`.><''-?H_X(\&Z7\/O"6E>'-&MQ;:9IMNMO#&/0=2?4DY)/<DUN45&&PE/"
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MK2]$L5V6FG6L=K$/]E%"C^5:E%%>FE961^<3G*I)SF[MZL****9`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`'RA\4=6@_X;W^&%OJ,R16EOHTY
MMO,;"^?()@,<]3@#\A]=?X_)!\9_C;\/?AG9.+NTTFZ_X2+7S&V5@BCXBC;'
M1G)(P>Q%;W[2W[*=E^T%>Z+JD.N2^'=;TQ3"MW'#YHDB)W;2-RD$')!![FNL
M^!7P"T'X$:#<VFFS3ZGJM\XEU#5[TYGNG'3/7"CLN3U/4G->6J564YPDO=;O
M>_332WR^X_39YIEM'`X3&T:K^LTJ;IJ'*[*3<O?YMMI726O-8].HHHKU#\R"
BBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
